Antiretroviral drug resistance among antiretroviral‐naïve and treatment experienced patients infected with HIV in Iran
- 17 April 2014
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 86 (7) , 1093-1098
Abstract
Resistance to antiretroviral therapy (ART) threatens the success of programs to reduce HIV morbidity and mortality, particularly in countries with few treatment options. In the present study, genotype and phenotype data from ART-naïve and experienced hospitalized patients infected with HIV in Tehran, Iran were used to assess the prevalence and types of transmitted (TDR) and acquired drug resistance (ADR) mutations. All 30 participants naïve to ART and 62 of 70 (88.6%) participants receiving ART had detectable viral loads. Among participants receiving ART with sequencing data available (n = 62), 36 (58.1%) had at least one drug resistance mutation; the most common mutations were K103N (21.0%), M184V (19.4%), and the thymidine analogue mutations. Seven (11.3%), 27 (43.5%), and two (3.2%) of these participants had resistance to one, two, and three drug classes, respectively. High-level resistance to efavirenz (EFV) was more common among participants on EFV-based regimens than high-level lopinavir/ritonivar (LPV/r) resistance among those on LPV/r-based regimens (55.3% vs. 6.7%, P < 0.0001). Two (6.7%) antiretroviral-naïve participants had K103N mutations. These findings document an alarmingly high frequency of multiple HIV drug class resistance in Iran, confirm the presence of TDR, and highlight the need for systematic viral load monitoring and drug resistance testing, including at diagnosis. Expanded access to new antiretroviral medications from additional drug classes is needed. J. Med. Virol. 86:1093–1098, 2014.Keywords
This publication has 14 references indexed in Scilit:
- Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011PLOS ONE, 2013
- Modeling the emergence of HIV-1 drug resistance resulting from antiretroviral therapy: Insights from theoretical and numerical studiesBioSystems, 2012
- Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysisAntiviral Research, 2011
- Transmitted HIV-1 Drug Resistance Among Young Men of Color Who Have Sex With Men: A Multicenter Cohort AnalysisJournal of Adolescent Health, 2011
- Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patientsAIDS, 2010
- Antiretroviral drug resistance in HIV-infected patients in ColombiaInternational Journal of Infectious Diseases, 2010
- Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot studyArchives of Virology, 2010
- Prevalence of HIV‐1 Drug Resistance after Failure of a First Highly Active Antiretroviral Therapy Regimen in KwaZulu Natal, South AfricaClinical Infectious Diseases, 2008
- Class-Sparing Regimens for Initial Treatment of HIV-1 InfectionNew England Journal of Medicine, 2008
- Antiviral Activity of Lamivudine in Salvage Therapy for Multidrug‐Resistant HIV‐1 InfectionClinical Infectious Diseases, 2005